Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737964) titled 'ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms' on July 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University Hospital, Montpellier

Condition: Heart Failure

Intervention: Drug: Acetazolamide and furosemide

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: October 2026

Target Sample Size: 366

Countries of Recruitment: France

To know more, visit https://clinicaltrials.gov/study/NCT07737964

Disclaimer: ...